Winmac Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-12-2024
- Paid Up Capital ₹ 1.00 M
as on 18-12-2024
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Winmac Laboratories
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sarla Tiwari, Suman Tiwari, Sahil Tiwari, and One other member serve as directors at the Company.
- CIN/LLPIN
U51357CH1998PLC020930
- Company No.
020930
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Jan 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Winmac Laboratories Limited offer?
Winmac Laboratories Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Allopathic Cough Syrup, Guaiphenesin Cough Syrup, Ferrous Ascorbate Syrup, Vitamin B Complex Syrup, Mineral Supplement, Calcium Gluconate, Pharmaceutical Medicine, Lycopene Syrup.
Who are the key members and board of directors at Winmac Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Tiwari  | Director | 01-Jan-2018 | Current |
| Sarla Tiwari | Director | 26-Apr-2024 | Current |
| Suman Tiwari | Director | 26-Oct-2001 | Current |
| Pankaj Mishra | Director | 16-Sep-2021 | Current |
Financial Performance of Winmac Laboratories.
Winmac Laboratories Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Winmac Laboratories?
In 2017, Winmac Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Macwin Pharmaceuticals Private LimitedActive 21 years 11 monthsSuman Tiwari and Sahil Tiwari are mutual person
- Macwin Laboratories LimitedActive 18 years 7 months
Suman Tiwari, Sahil Tiwari and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Winmac Laboratories?
Unlock and access historical data on people associated with Winmac Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winmac Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winmac Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
